Why analytics can offer a helping hand at safety net hospitals

Congress’ recent directive to Medicare to ease the burden of hospital readmission penalties on safety net hospitals that serve low-income patients was definitely a step in the right direction. After all, once patients with high social needs are discharged, there is much that’s outside the hospital’s control. It isn’t fair to penalize providers when they… Read More »

Venclexta trial deaths force AbbVie, Roche to stop recruiting myeloma patients

AbbVie and Roche are looking to move key oncology drug Venclexta deeper into the blood cancer arena, but their ambitions in multiple myeloma just took a hit. The FDA has halted enrollment in all of Venclexta’s myeloma trials, the companies said Tuesday. The reason? The Venclexta arm of a phase 3 study, dubbed Bellini, turned up a higher… Read More »